CAC vs TECH
Camden National Corporation (CAC) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Camden National Corporation (CAC) is a banks - regional company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CAC revenue for 2024-12-31 was $35.7M. Net income was $53.0M. Revenue was up 6.3% from 2023-12-31 to 2024-12-31. CAC currently screens at market cap $867.6M and trailing P/E 10.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CAC currently screens at market cap $867.6M and trailing P/E 10.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CAC and TECH stock pages for the full models.
Not investment advice.